Literature DB >> 9832441

Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain.

C Vaccari1, S J Lolait, N L Ostrowski.   

Abstract

The comparative distributions of the vasopressin V1b receptor (V1bR) and the oxytocin receptor (OTR) messenger RNAs (mRNAs) are described in male rat brain using in situ hybridization histochemistry. V1bR transcripts were present in forebrain and hypothalamus and were less abundant in mid- and hindbrain regions, similar to the gradient observed with OTR transcripts. Microscopic analyses indicated that V1bR expressing cells typically demonstrated the morphology of neurons and confirmed V1bR gene expression in regions including the olfactory bulb, supraoptic, suprachiasmatic, and dorsomedial hypothalamic nuclei, piriform and entorhinal cortices, hippocampus, substantia nigra, and dorsal motor nucleus of the vagus. Most regions that expressed V1bR mRNA also expressed OTR mRNA, although OTR gene expression was much more extensive than that of the V1bR. V1bR and OTR mRNA distributions were distinct from each other and from that of the V1a receptor mRNA in brain. A few brain regions express only V1bR transcripts such as the dorsomedial hypothalamic nucleus and the external plexiform layer of the olfactory bulb. Other brain regions, such as the fields of Ammon's horn, the suprachiasmatic nucleus, the substantia nigra pars compacta, and the piriform cortex express mRNAs that encode all three receptor subtypes (V1a, V1b, and OTR), whereas brain areas including the red nucleus and supraoptic nucleus express V1bR and OTR transcripts only. These data suggest functional specialization of the V1b, OTR and V1a receptors in brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832441     DOI: 10.1210/endo.139.12.6382

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  78 in total

1.  Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder.

Authors:  Izelle Labuschagne; K Luan Phan; Amanda Wood; Mike Angstadt; Phyllis Chua; Markus Heinrichs; Julie C Stout; Pradeep J Nathan
Journal:  Neuropsychopharmacology       Date:  2010-08-18       Impact factor: 7.853

Review 2.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

Review 3.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

Review 4.  Neural integration of satiation and food reward: role of GLP-1 and orexin pathways.

Authors:  Diana L Williams
Journal:  Physiol Behav       Date:  2014-03-18

5.  Effects of Chronic Oxytocin Administration and Diet Composition on Oxytocin and Vasopressin 1a Receptor Binding in the Rat Brain.

Authors:  Sara M Freeman; Julie Ngo; Bhavdeep Singh; Megan Masnaghetti; Karen L Bales; James E Blevins
Journal:  Neuroscience       Date:  2018-07-31       Impact factor: 3.590

6.  Proximal colon distension induces Fos expression in oxytocin-, vasopressin-, CRF- and catecholamines-containing neurons in rat brain.

Authors:  Lixin Wang; Vicente Martínez; Muriel Larauche; Yvette Taché
Journal:  Brain Res       Date:  2008-10-15       Impact factor: 3.252

7.  Role of vasopressin V1a receptor in ∆9-tetrahydrocannabinol-induced cataleptic immobilization in mice.

Authors:  Nobuaki Egashira; Emi Koushi; Takayuki Myose; Akito Tanoue; Kenichi Mishima; Ryota Tsuchihashi; Junei Kinjo; Hiroyuki Tanaka; Satoshi Morimoto; Katsunori Iwasaki
Journal:  Psychopharmacology (Berl)       Date:  2017-09-14       Impact factor: 4.530

Review 8.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

9.  Attenuated stress response to acute restraint and forced swimming stress in arginine vasopressin 1b receptor subtype (Avpr1b) receptor knockout mice and wild-type mice treated with a novel Avpr1b receptor antagonist.

Authors:  J A Roper; M Craighead; A-M O'Carroll; S J Lolait
Journal:  J Neuroendocrinol       Date:  2010-11       Impact factor: 3.627

10.  A complex selection signature at the human AVPR1B gene.

Authors:  Rachele Cagliani; Matteo Fumagalli; Uberto Pozzoli; Stefania Riva; Matteo Cereda; Giacomo P Comi; Linda Pattini; Nereo Bresolin; Manuela Sironi
Journal:  BMC Evol Biol       Date:  2009-06-01       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.